AxoGen, Inc. (AXGN) vs LivaNova PLC (LIVN)
- AxoGen, Inc. AXGN 49.50 +1.54%
- LivaNova PLC LIVN 90.63 −0.56%
AxoGen, Inc. and LivaNova PLC are both Medical Devices companies. LivaNova PLC is the larger, with a market value of $5.0B against $2.9B — 1.7× the size. AxoGen, Inc. has negative trailing earnings, so its P/E is not meaningful; LivaNova PLC trades at 25.6×. AxoGen, Inc. grew revenue faster over the last twelve months: 24.3% against 11.7%. LivaNova PLC has the higher net margin (13.0% vs −12.0%) and the higher return on invested capital (9.14% vs −5.27%). Across the 19 metrics below, LivaNova PLC leads on 13 and AxoGen, Inc. on 6.
Valuation
Profitability
| Metric | AXGN | LIVN | Medical Devices median |
|---|---|---|---|
| Gross margin | 74.18% | 67.84% | 57.76% |
| Operating margin | (5.17%) | 10.75% | (15.07%) |
| Net margin | (11.96%) | 13.01% | (14.45%) |
| Free cash flow margin | 7.50% | 9.05% | (3.88%) |
| Return on equity | (10.35%) | 15.50% | (10.35%) |
| Return on assets | (8.33%) | 7.44% | (17.26%) |
| Return on invested capital | (5.27%) | 9.14% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack